Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
Blog
Page 2
Blog
Blog
The Pandemic is Over, But Pandemic Policies Are Not
Raymond March
-
September 19, 2023
0
Blog
FDA Efforts to Curb Youth Vaping Continue to Come Up Short
Raymond March
-
September 5, 2023
0
Blog
The FDA Loosens Blood Donation Restrictions, Finally
Raymond March
-
July 7, 2023
0
Blog
Recent Attacks on Recreational Marijuana Legalization Are All Smoke
Raymond March
-
June 22, 2023
0
Blog
Are Insulin Prices About to Drop? The Devil is in the Details
Raymond March
-
April 28, 2023
0
Blog
FDA’s Rare Positive Move
Raymond March
-
April 4, 2023
0
Blog
Insulin Price-Caps: A Solution or a Recipe for Rationing?
Raymond March
-
March 31, 2023
0
Blog
When is a Drug Safe and Effective Enough?
Raymond March
-
March 3, 2023
0
Blog
The FDA is Too Little Too Late in Tinkering with Covid-19 Booster Schedules
Raymond March
-
February 23, 2023
0
Blog
Deregulation Remains Our Best Hope to Combat Alzheimer’s Disease
Raymond March
-
February 17, 2023
0
1
2
3
...
13
Page 2 of 13
